Illustrating the safety of a new drug treatment designed for spinal cord injury

New orally available drug for spinal cord injury found to be safe and tolerable in healthy participants.

Massachusetts $181,722 pot boss past weeded out – The Cannabist

After failing to publicly disclose the chairwoman’s prior involvement in a massive outdoor marijuana growing operation, the state’s Cannabis Control Commission has determined their boss

May 3, 2023

Evotec and Crohn´s & Colitis Foundation enter agreement to advance drug discovery for novel IBD therapies – Biotech Investments

EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec and Crohn´s & Colitis Foundation enter agreement to advance drug discovery for novel IBD therapies 10.01.2024 /

January 11, 2024

First Opinion readers on Noah Lyles and Covid-19, the dearth of geriatricians, PBMs, and more

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers,

August 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.